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The objective of the present study was to investigate whether ego-dystonic and ego-syntonic suicidal ideation occurred at diﬀerent
frequencies during antidepressant therapy. A blindevaluationhasbeen performed onrecords of 100suicides witha primarysevere
depression and 100 matched controls, admitted to the Department of Psychiatry, Lund, Sweden. Ego-dystonic suicidal ideation
was more commonly reported during adequate treatment as compared to ego-syntonic ideation (P = .004). Men who committed
suicide during adequate antidepressant therapy more often reported ego-dystonic suicidal ideation earlier in their lives compared
with those who were not treated (P = .0377). This may indicate that treatment failure for ego-dystonic ideation was a precursor
of their suicides. Consequently, ego-dystonic ideation seems to show a poorer response to antidepressant therapy as compared
to ego-syntonic ideation, which may be more directly related to depression. Ego-dystonic ideation is proposed to be related to
depressive psychosis.
1.Introduction
Suicidal ideation is a precursor of completed suicide, and
it is important to evaluate the eﬀect of treatment on its
occurrence. Reduction of suicidal ideation has been shown
during antidepressant medication [1–5], or at least in some
individuals [6, 7], and after ECT [8–10]. However, an
emergence of suicidal tendencies has also been found [11–
13].
These studies were based on undiﬀerentiated suicidal
ideation.Previousresearch byRingelon suicidalideationhas
distinguished between active and passive suicidal ideation,
dependingonwhethertheindividualkeepssomesubjectively
active position or is passively overwhelmed by suicidal
thoughts [14]. In addition, Akiskal has described that
some depressed people could be tormented with suicidal
obsessions and constantly resist unwanted suicidal urges or
impulses to destroy themselves, as opposed to another group
who may harbour elaborate plans, carefully preparing a will,
and so forth [15].
The present study uses a phenomenological distinction
between ego-syntonic and ego-dystonic suicidal ideation
based on previous studies in our group. We have found that
suicidal ideation “beyondone’s own will” (i.e., ego-dystonic)
was related to completed suicide in a severe depression with
psychotic features for men and bipolar disorder for both
men and women, while the more rational/wanted items on
Beck’s SSI were not related [16]. Previous studies have also
shown that there were generally similar rates of adequate
antidepressant treatment and also improvement in suicides
and controls in the long-term course [17] and at suicide
[18]. Consequently, the increased suicide risk for patients
who report suicidal ideation “beyond one’s own will” may
be resistance to antidepressant therapy.
The aim of the present study was to compare ego-
dystonic and ego-syntonic ideation during adequate antide-
pressant treatment, to identify any diﬀerential responses
to treatment. The following questions were addressed:
ﬁrstly, was ego-dystonic compared to ego-syntonic suicidal
ideation more often reported during adequate treatment in2 Depression Research and Treatment
the long-term course: secondly, had those who committed
suicideduringadequateantidepressanttreatmentmoreoften
reported ego-dystonic suicidal ideation earlier in their lives,
indicating a lack of response to treatment for this type of
ideation? Men and women were compared.
2.Materialsand Methods
2.1. Sample. In the 1950s and 1960s, all in-patients at
the Department of Psychiatry, University Hospital, Lund
were rated on a multiaxial diagnostic schedule at discharge
[19]. This database enabled the selection of patients with
a prospectively rated severe depression/melancholia for an
investigation into suicide.
A total of 1,206 patients received this diagnosis (506
men and 700 women). Their mortality was followed-up in
three sessions—to January 1, 1984 to January 1, 1998, and
to Feb 15 2010. There were 116 suicide victims up to 2010.
Deceased persons were grouped according to the primary
cause of deathas classiﬁed by the Central Bureau of Statistics
usingtheInternationalClassiﬁcationofDisease[20–22].The
sampling procedure is presented in Figure 1.
The case records were prepared for a thorough blind
evaluation by omitting the last sheet with information on
the suicide, as has previously been described [23], and a
similar procedure was used at second and third follow-ups.
Secondary depressions, mainly alcoholism, were excluded.
This left us with 100 completed suicides, 44 men and 56
women, with a primary severedepression. Matched controls,
one for each suicide, were selected from the total sample
by the criteria of diagnosis, gender, year of birth, and index
admission year, which meant that they were the same age on
admission. The controls were selected on the basis of being
alive and monitored up until the death of the suicide victim
they matched and so were monitored for a similar length of
time.
A retrospective diagnosis according to DSM-IV [24]h a s
been performed based on the symptoms reported in the
records. It turned out that at least 91% of the patients met
the criteria for a major depressive disorder with melancholic
or psychotic features; of these, 47% were melancholic and
63% psychotic, and 22% had a bipolar disorder. The rates
in suicides and controls were the same.
Comorbid obsessional-compulsive symptoms blindly
scored in the case records in the ﬁrst follow-up did not
signiﬁcantly diﬀerentiate between suicides and controls
(13% versus 8%). Anxiety prospectively scored on the
multiaxial ratings did not diﬀerentiate (35% versus 33%).
Being married at index admission (blindly rated) was sig-
niﬁcantly more common in female controls but social class
did not diﬀerentiate for men or women [23]. Prospective
scores (multiaxial ratings) of brittle/sensitive personality and
heredity for psychosis were signiﬁcantly more common in
male suicides than male controls [23].
2.2. Suicidal Ideation. Suicidal ideation was scored based on
the reports in the case records according to Beck’s Scale for
Suicidal Ideation—SSI [25], as described in a previous paper
[16].However,sometypesofideationreportedintherecords
did not ﬁt in the basically rational thinking in SSI and those
items were scored separately. Of the latter “suicidal ideation
beyond one’s own will” was signiﬁcantly related to suicide.
The occurrence of ego-dystonic suicidal ideation, or
“beyond one’s own will” [16], was compared with ego-
syntonic thoughts of suicide during adequate antidepressant
therapy. These correspond to the dichotomy suggested by
Ringel [14]a n dA k i s k a l[ 15]. The ratings were as follows.
(i) Ego-dystonicsuicidal ideation.Unwanted urges to take
one’s own life; suicidal ideation “beyond one’s own
will”; fear of killing oneself; a compulsion to kill
oneself; and nightmares about suicide. (Three cases
of imperative hallucinations demanding suicide were
found in the control group only; they overlapped
with irrational/unwanted ideation in all but one case
and were excluded.)
(ii) Ego-syntonic suicidal ideation (items on Beck’s SSI,
English version [25]). Evidence of desire to take one’s
own life: item 4, desire to make an active suicide
attempt;item12,method considered;item16,partial
or complete preparations; item 17, suicide notes
completed, and item 18, act in anticipation of death.
All scoring was performed by the same rater, who was
blind to suicidal outcome and to the scoring of antidepres-
sant therapy and repeated on a later occasion to enhance the
reliability.(Beck’sSSIwasusedforthescoringaswellasitems
describing “suicidal ideation beyond one’s own will” or ego-
dystonic ideation [16].)
2.3. Antidepressant Therapy. Antidepressant therapy during
thecourseofdepression wasevaluatedaccordingtoOttosson
[26]forall follow-ups(1984,1998,2010)and wasasfollows.
(1) Adequate doses were scored as follows: a full dose of
at least 150mg of tricyclic or tetracyclic antidepres-
sants should be continued for at least 2 months. (A
few patients who had received monoamine oxidase
inhibitors (MAO) inhibitors were included.)
(2) ECT (adequate treatment): a series of at least six
treatmentswasconsideredadequate(allpatientswere
given three treatments a week). (According to the
tradition of the clinic, treatment was sometimes dis-
continued after 4 seizures. These cases were included
if there was a persistent eﬀect on depression.)
(3) ECT and continuation treatment with antidepres-
sants: continuation treatment should be initiated
within 2 weeks after the last ECT. No sign of relapse
of depression should have been reported.
(4) Lithium-prophylaxis was also scored (and in one case
valproatic acid).
Treatment with neuroleptics was also noted. Adequate
treatment of depressive episodes was similar throughout
the course of depression in suicides and controls and so
was improvement, as described in a previous paper [17].
Suicidal ideation was scored as to whether it was reported
during ongoing adequate antidepressant therapy or whenDepression Research and Treatment 3
Secondary depressions excluded
116 suicides 100 suicides (primary depressions)
(51 patients in treatment within 6 months before suicide)
1,206 cases of severe depression/melancholia
1956 1969 2006
(49 patients not in treatment within 6 months before suicide)
Figure 1: Flow-diagram for the sample of patients with severe depression admitted to the Department of Psychiatry, Lund University
Hospital.
untreated. Antidepressant medicationshould havebeenused
at least four weeks in order to be considered to have
an antidepressant eﬀect, and a full course of ECT should
have been completed. For those who received adequate
antidepressant therapy, occurrence of ego-dystonic and ego-
syntonic suicidal ideation during adequate treatment was
scored, in order to evaluate whether relief of depressive
symptoms also included relief of suicidal ideation.
Finally, treatment at suicide was related to type of
ideation previously reported. In all, 51 members of the
sample were in contact with the department within six
months before suicide(22 men and 29 women). This contact
was supposed to concern their last episode.
The study was approved by Lund University Medical
Ethics Committee 1985 and 2003.
2.4. Statistics. An χ2 test was used for comparisons between
groups and Fisher’s exact test, when applicable. Wilcoxon’s
test was used for a comparison of ranks. A sign test was used
for a comparison between type of suicidal ideation during
adequate treatment, as almost all patients had received
adequate treatment on some occasion and could therefore
report suicidal ideation during treatment. By using a sign
test, those who had reported both ego-dystonic and ego-
syntonic ideation on diﬀerent occasions were ascribed a zero
value, and those who had reported only one type of ideation
were compared.
3.Results
3.1. Report of Suicidal Ideation and Long-Term Treatment.
Treatment of depressive episodes in the long-term course
was compared for suicides and controls. A vast majority had
received adequate antidepressant therapy at some time, 93%
of the suicide group and 95% of the control group. Type of
treatment, such as ECT, antidepressant pharmacotherapy, or
mood-stabilisers did not vary.
Suicidal ideation could not be shown to occur more
often among those who were less adequately treated. Within
the suicide group, as well as the control group, suicidal
ideators showed similar rates of adequately treated episodes
as did nonideators (66% versus 79% in the suicide group
and 76% versus 69% in the control group). Rates of ECT,
antidepressant pharmacotherapy, and Lithium were similar

























Ego-dystonic ideation Ego-syntonic ideation
Figure 2: The proportion of reported ego-dystonic and ego-
syntonic suicidal ideation during adequate treatment related to the
total number of reported ego-dystonic and ego-syntonic ideation
(percent).
3.2. Type of Ideation Related to Treatment and Long-Term
Course. Suicides and controls showed similar rates of treat-
ment and were analysed together. A sign test showed a
signiﬁcant increased risk for patients with ego-dystonic
suicidal ideation as compared to ego-syntonic ideation
during adequate antidepressant therapy (24 ego-dystonic
only versus 8 ego-syntonic only; P<. 004).
The proportion of ego-dystonic and ego-syntonic
ideation events reported during adequate treatment in
relation to the total number of ideation events is presented
in Figure 2. The proportion of individuals who reported
ego-dystonic or ego-syntonic ideation during antidepressant
therapy only in relation to the total number of individuals
who reported the type of ideation is presented in Figure 3.
A clear peak for ego-dystonic compared to ego-syntonic
suicidal ideation was found during adequate treatment.
3.3. Type of Ideation Related to Treatment at Suicide. Suicidal
ideationpreviouslyreportedwascomparedforthosepatients
who had been in contact and adequately treated before
suicide and those who were untreated, being in contact or
not (Table1). Maleswho committedsuicideduring adequate
treatment had more often previously reported ego-dystonic
suicidal ideation in comparison to all untreated (7/15 versus
5/29, chi-square = 4.32, P<. 038). Furthermore, if only
those who were in contact before suicide were compared,
as i g n i ﬁ c a n td i ﬀerence for ego-dystonic ideation between4 Depression Research and Treatment
Table 1: Ego-dystonic and ego-syntonic suicidal ideation related to treatment by contact and gender.








Contact and treatment within 6
months before suicide 7 11 15 3 13 17
Contact and no treatment within 6
months before suicide 0 6 7 6 10 12
No contact before suicide 5 17 22 3 15 27
I d e a t i o n T o t a l 1 23 44 41 23 85 6
(Note that one patient could have both or none of the types of ideation. Thus the rows and columns could not be totalled.)
Ego-dystonic ideation reported by men in contact and treated versus all other men: chi-square = 4.31, P<. 038.
Ego-dystonicideation reported by men in contact and treated versus in contact and untreated: Fisher’s exact test = 0.038.























Type of ideation: number of individuals
Ego-dystonic ideation Ego-syntonic ideation
Figure 3:The proportionofindividuals whoreported ego-dystonic
and ego-syntonic suicidal ideation during adequate treatment only,
related to the total number of individuals who had at some time
reported ego-dystonic and ego-syntonic ideation (percent).
treated and untreated remained (7/15 versus 0/7, Fisher’s
exact test P = .038). All the seven patients with ego-dystonic
ideation who committed suicide despite adequate treatment
had previously been diagnosed with psychotic features. Of
these, two were prescribed additional neuroleptics, only
one as an antipsychotic. There was a nonsigniﬁcant trend
for males to report ego-dystonic suicidal ideation during
treatment more often than women (7/15 versus 3/17, chi-
square = 3.12; P = .078).
4.Discussion
Firstly, ego-dystonic suicidal ideation was shown to be
more commonly reported during adequate antidepressant
therapy as compared with ego-syntonic suicidal ideation.
Secondly, the ego-dystonic ideation previously in life was
more often reported by men who committed suicide dur-
ing antidepressant treatment as compared to other male
suicides, being in contact at suicide or not. We do not
know whether the patients who previously had reported
ego-dystonic suicidal ideation also had these thoughts at
the time of suicide. However, the fact that ego-dystonic
ideation also appeared resistant to antidepressant treatment
in the long-term course justiﬁes an assumption that suicide
may have been preceded by this type of suicidal thought.
The association with accomplished suicide was found only
i nt h em a l eg r o u p .I ti sp o s s i b l et h a tm e nm o r eo f t e na c t
on this type of suicidal feeling, as men are more prone
to fatal suicidal acts [27]. The occurrence of ego-dystonic
suicidal ideation and accomplished suicide during adequate
antidepressant therapy may be due to a lack of response for
this type of suicidal ideation. In a previous study, we found
evidence that urges to make suicide attempts may remain
during adequate treatment with antidepressants, though the
acts were often interrupted [17]. That ﬁnding is compatible
with the occurrence of ego-dystonic suicidal ideation during
antidepressant therapy found in the present study. Ego-
syntonic suicidal ideation appears to show a better response
to antidepressant therapy as compared to ego-dystonic
suicidal ideation. Perhaps ego-syntonic ideation is part of
a depressive disorder and consequently reduced when there
is a relief of depression. On the other hand, ego-dystonic
ideation appears to show a poor response, indicating that it
may occur independent of depressive symptoms. In another
previous study [16], we found a correlation between ego-
dystonic suicidal ideation (“beyond one’s own will”) and
psychosis.Allthemenwhocommittedsuicideduringantide-
pressant therapy had suﬀered depression with psychotic
features. As ego-dystonic suicidal ideation both appeared
resistant to antidepressant treatment and was also related to
psychosis, there is an interesting possibility that this type
of suicidal ideation may actually be psychotic in nature.
According to other investigators, patients with psychotic
depression seem to be much more likely to exhibit high
levelsofsuicidalideationfollowingtreatmentcomparedwith
patientswithout psychotic features[28],which is compatible
with the present ﬁndings. Risperidone augmentation to
antidepressants has also recently been shown to reduce
suicidal ideation in major depressive disorder [29], a ﬁnding
compatiblewith ahypothesisof“psychoticsuicidalideation”.
However, none of these studies considered the type of
ideation.Depression Research and Treatment 5
The present study deals with a sample of severely
depressed patients. Severe depression has been shown to
be a predominant diagnosis among suicide victims [30]
and to have an increased risk for completed suicide as
compared to major depression without severe features [31,
32]. The records were well written and very informative
and a great number of statements on suicidal ideation were
available, but an important weakness of this study is the
lack of systematic inquiry of suicidal ideation. On the other
hand, the study builds on continuous reports in the case
records noted at the time, thereby minimising the eﬀect
of recall bias, which is a strength. Furthermore, in making
a comparison between the occurrences of diﬀerent types
of ideation during treatment, it is assumed that patients
are equally prone to communicate those types of suicidal
ideation, whether under treatment or not. This is probable
but cannot be proved. There were some diﬀerences between
suicides and controls concerning personality and marital
status that is shown in a previous paper [23]. However,
there is no indication these would inﬂuence the diﬀerent
responses for types of ideation, and the improvement rates
on antidepressant therapy were the same for suicides and
controls. Type of suicidal ideation was compared during
diﬀerenttypesoftreatment, which may have diﬀerentmodes
of action. However, the common objective is relief of depres-
sion through the use of ECT, antidepressants, and mood-
stabilisers, which work in much the same way. Finally, the
antidepressants prescribed were generally tricyclics, which
are no longer a ﬁrst choice. However, a similar eﬀect of
these drugs as compared to selective serotonin reuptake
inhibitors and serotonin norepinephrine reuptake inhibitors




Ego-dystonic suicidal ideation appeared to be more fre-
quent during adequate antidepressant therapy than ego-
syntonic suicidal ideation. The distinction between these
types of ideation during antidepressant treatment there-
fore appears to be important in eﬀorts to predict and
prevent suicide. We propose that ego-syntonic ideation
may be a part of a depressive disorder and thereby
reduced by antidepressant therapy, while ego-dystonic
ideation occurs more frequently during adequate ther-
apy, perhaps indicating that it may be psychotic in
nature.
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